The Immunopharmacology Research Group has more than 20 years of experience on investigating inflammation and cellular mechanisms in arthritis, asthma, obesity and other inflammatory states.
We contribute to drug development by
- studying mechanisms driving inflammatory diseases to discover novel treatment targets for anti-inflammatory and immunomodulatory drugs
- testing drugs and compounds in our state-of-the-art in vitro and in vivo disease models
- finding ways to improve existing treatments
- investigating biomarkers and diagnostic applications in inflammatory diseases in collaboration projects with clinicians
Our current core research interests include
- inflammatory response and inflammatory gene expression
- TRPA1 in inflammation and inflammatory pain
- MAP kinase / phosphatase pathways
- adipokines and their role as effectors, regulators and biomarkers in inflammation
- macrophage and T cell-derived cytokines in inflammatory lung diseases, allergy, rheumatoid arthritis and osteoarthritis
Our spin-off research projects investigating anti-inflammatory and metabolic effects of arctic pine and berries can be found on their own webpages
- High-value health-promoting compounds from arctic berries
https://research.tuni.fi/taiga/in-english/ - High-value health-promoting compounds from arctic pine and berries
https://research.tuni.fi/arvoaineet/in-english/
